- Home
- ETNB vs PHIN Comparison
ETNB vs PHIN Comparison
Compare ETNB & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- PHIN
- Stock Information
- Founded
- ETNB 2018
- PHIN 2023
- Country
- ETNB United States
- PHIN United States
- Employees
- ETNB N/A
- PHIN N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- PHIN
- Sector
- ETNB Health Care
- PHIN
- Exchange
- ETNB Nasdaq
- PHIN Nasdaq
- Market Cap
- ETNB 1.5B
- PHIN 1.7B
- IPO Year
- ETNB 2019
- PHIN N/A
- Fundamental
- Price
- ETNB $10.12
- PHIN $47.35
- Analyst Decision
- ETNB Strong Buy
- PHIN Buy
- Analyst Count
- ETNB 8
- PHIN 5
- Target Price
- ETNB $26.43
- PHIN $52.20
- AVG Volume (30 Days)
- ETNB 2.2M
- PHIN 482.0K
- Earning Date
- ETNB 08-04-2025
- PHIN 07-24-2025
- Dividend Yield
- ETNB N/A
- PHIN 2.28%
- EPS Growth
- ETNB N/A
- PHIN N/A
- EPS
- ETNB N/A
- PHIN 1.75
- Revenue
- ETNB N/A
- PHIN $3,336,000,000.00
- Revenue This Year
- ETNB N/A
- PHIN N/A
- Revenue Next Year
- ETNB N/A
- PHIN $1.55
- P/E Ratio
- ETNB N/A
- PHIN $27.07
- Revenue Growth
- ETNB N/A
- PHIN N/A
- 52 Week Low
- ETNB $4.16
- PHIN $36.25
- 52 Week High
- ETNB $11.84
- PHIN $57.23
- Technical
- Relative Strength Index (RSI)
- ETNB 58.34
- PHIN 68.76
- Support Level
- ETNB $9.45
- PHIN $44.26
- Resistance Level
- ETNB $10.34
- PHIN $45.13
- Average True Range (ATR)
- ETNB 0.52
- PHIN 1.22
- MACD
- ETNB -0.07
- PHIN 0.50
- Stochastic Oscillator
- ETNB 69.34
- PHIN 87.54
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About PHIN PHINIA Inc.
Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.